News Feed Item

2014 Report on Select Cardiovascular Drugs in the GCC Region

DUBLIN, Ireland, January 27, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/7dmdjw/market_for_select) has announced the addition of the "2014 Report on Select Cardiovascular Drugs in the GCC Region" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The local governments are increasingly focusing on improving the health and living standards of the population. Contraints in local manufacturing capacity and thriving counterfeit drugs market pose a major challenge but improved regulatory mechanism, increase in private sector participation coupled with rising private and public sector outlay and spend on healthcare presents a promising future for the industry.

This report focuses on the market for select cardiovascular drugs in the GCC region. Various market drivers in terms of changing lifestyle and rising disease incidence among the population has led to higher consumption of cardiovascular drugs in the region. Sensing the latent market opportunity, global pharma majors such as Novartis, Abbott, AstraZeneca have set up operations in the GCC region through local joint venture and distribution.

In addition to market forecast upto 2016, the report also provides interesting insights into key molecules used, top brands, drug prices, procurement process among government and retail institutions. The report will serve as a effective guide for the drug companies, distributors, hospitals and other stakeholders who wish to enter the GCC healthcare market. The report also has profiles of companies and distributors in the GCC region." 

Key Topics Covered: 

1. Methodology

2. Report Coverage
2.1 Geography
2.2 Therapeutic groups & drug molecules

3. Glossary of terms

4. Executive summary

5. Healthcare sector in GCC
5.1 Overview of the healthcare sector
5.2 Healthcare infrastructure

6. Pharmaceutical market in GCC
6.1 Overview of the pharmaceutical market
6.2 Domestic manufacturing
6.3 Foreign trade
6.4 Counterfeit drugs
6.5 Regulatory environment and registration procedure
6.6 Drug sourcing and pricing regulation
6.7 Share of purchase by Government vs. Private

7. Cardiovascular market for select drugs in GCC
7.1 Key health indicators
7.2 Disease incidence levels
7.3 Share of cardiovascular drugs by: hypertension, coronary artery disease & hyperlipidemia
7.4 Market size of cardiovascular drugs in GCC
7.5 Prices of Cardiovascular drugs in GCC
7.6 Top brands/suppliers of cardiovascular drugs in GCC

8. Profiles of key domestic pharmaceutical manufacturers
8.1 Tabuk Pharmaceuticals Manufacturing Company
8.2 Jamjoom Pharma
8.3 Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
8.4 Julphar - Gulf Pharmaceutical Industries
8.5 Global Pharma
8.6 Neo Pharma
8.7 Kuwait Saudi Pharmaceutical Industries (KSPICO)
8.8 National Pharmaceutical Industries Co. (NPI)
8.9 Oman Pharmaceutical Products Co. L.L.C 
8.10 Profiles of key pharmaceutical distributors in GCC

9. Annexure - Drugs price details by country - 2012

Companies Mentioned:

  • AstraZeneca
  • Global Pharma
  • Jamjoom Pharma
  • Julphar - Gulf Pharmaceutical Industries
  • Kuwait Saudi Pharmaceutical Industries
  • Merck & Co., Inc
  • National Pharmaceutical Industries Co
  • Neo Pharma
  • Novartis International AG
  • Oman Pharmaceutical Products Co. L.L.C
  • Pfizer, Inc
  • Sanofi S.A.
  • Saudi Pharmaceutical Industries & Medical Appliances Corporation
  • Tabuk Pharmaceuticals Manufacturing Company

For more information visit http://www.researchandmarkets.com/research/7dmdjw/market_for_select

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Dion Hinchcliffe is an internationally recognized digital expert, bestselling book author, frequent keynote speaker, analyst, futurist, and transformation expert based in Washington, DC. He is currently Chief Strategy Officer at the industry-leading digital strategy and online community solutions firm, 7Summits.
DXWordEXPO New York 2018, colocated with CloudEXPO New York 2018 will be held November 11-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI, Machine Learning and WebRTC to one location.
@DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises - and delivering real results.
DXWorldEXPO LLC announced today that Dez Blanchfield joined the faculty of CloudEXPO's "10-Year Anniversary Event" which will take place on November 11-13, 2018 in New York City. Dez is a strategic leader in business and digital transformation with 25 years of experience in the IT and telecommunications industries developing strategies and implementing business initiatives. He has a breadth of expertise spanning technologies such as cloud computing, big data and analytics, cognitive computing, m...
Widespread fragmentation is stalling the growth of the IIoT and making it difficult for partners to work together. The number of software platforms, apps, hardware and connectivity standards is creating paralysis among businesses that are afraid of being locked into a solution. EdgeX Foundry is unifying the community around a common IoT edge framework and an ecosystem of interoperable components.
DXWorldEXPO LLC announced today that Kevin Jackson joined the faculty of CloudEXPO's "10-Year Anniversary Event" which will take place on November 11-13, 2018 in New York City. Kevin L. Jackson is a globally recognized cloud computing expert and Founder/Author of the award winning "Cloud Musings" blog. Mr. Jackson has also been recognized as a "Top 100 Cybersecurity Influencer and Brand" by Onalytica (2015), a Huffington Post "Top 100 Cloud Computing Experts on Twitter" (2013) and a "Top 50 C...
Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive...
Enterprises have taken advantage of IoT to achieve important revenue and cost advantages. What is less apparent is how incumbent enterprises operating at scale have, following success with IoT, built analytic, operations management and software development capabilities - ranging from autonomous vehicles to manageable robotics installations. They have embraced these capabilities as if they were Silicon Valley startups.
DXWorldEXPO LLC announced today that ICOHOLDER named "Media Sponsor" of Miami Blockchain Event by FinTechEXPO. ICOHOLDER give you detailed information and help the community to invest in the trusty projects. Miami Blockchain Event by FinTechEXPO has opened its Call for Papers. The two-day event will present 20 top Blockchain experts. All speaking inquiries which covers the following information can be submitted by email to [email protected] Miami Blockchain Event by FinTechEXPO also offers s...
Poor data quality and analytics drive down business value. In fact, Gartner estimated that the average financial impact of poor data quality on organizations is $9.7 million per year. But bad data is much more than a cost center. By eroding trust in information, analytics and the business decisions based on these, it is a serious impediment to digital transformation.
Daniel Jones is CTO of EngineerBetter, helping enterprises deliver value faster. Previously he was an IT consultant, indie video games developer, head of web development in the finance sector, and an award-winning martial artist. Continuous Delivery makes it possible to exploit findings of cognitive psychology and neuroscience to increase the productivity and happiness of our teams.
As DevOps methodologies expand their reach across the enterprise, organizations face the daunting challenge of adapting related cloud strategies to ensure optimal alignment, from managing complexity to ensuring proper governance. How can culture, automation, legacy apps and even budget be reexamined to enable this ongoing shift within the modern software factory? In her Day 2 Keynote at @DevOpsSummit at 21st Cloud Expo, Aruna Ravichandran, VP, DevOps Solutions Marketing, CA Technologies, was jo...
Predicting the future has never been more challenging - not because of the lack of data but because of the flood of ungoverned and risk laden information. Microsoft states that 2.5 exabytes of data are created every day. Expectations and reliance on data are being pushed to the limits, as demands around hybrid options continue to grow.
The standardization of container runtimes and images has sparked the creation of an almost overwhelming number of new open source projects that build on and otherwise work with these specifications. Of course, there's Kubernetes, which orchestrates and manages collections of containers. It was one of the first and best-known examples of projects that make containers truly useful for production use. However, more recently, the container ecosystem has truly exploded. A service mesh like Istio addr...
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...